Stay updated with breaking news from Panel Decision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last week, the Eleventh Circuit declined, 7–4, to reconsider en banc a divided panel's September 2020 decision barring incentive awards to class representatives for their work in class actions.
Last week, the Eleventh Circuit declined, 7–4, to reconsider en banc a divided panel’s September 2020 decision barring incentive awards to class representatives for their work in class...
The original Federal Circuit decision in Novartis Pharms. Corp. v. Accord Healthcare, Inc. was on the list of "written description" cases I covered in several conference programs this spring.
A need for a negative claim limitation often does not arise until the application is undergoing prosecution. For example, an unexpected prior art publication may be cited that requires an element the invention does not.
The original Federal Circuit decision in Novartis Pharms. Corp. v. Accord Healthcare, Inc. was on the list of “written description” cases I covered in several conference programs this...